Lmr Partners LLP Milestone Pharmaceuticals Inc. Transaction History
Lmr Partners LLP
- $10.5 Billion
- Q2 2025
Shares
2 transactions
Others Institutions Holding MIST
# of Institutions
55Shares Held
18.9MCall Options Held
160KPut Options Held
34.8K-
Black Rock Inc. New York, NY4.97MShares$9.45 Million0.0% of portfolio
-
Simplify Asset Management Inc. New York, NY2.83MShares$5.38 Million0.32% of portfolio
-
Rtw Investments, LP New York, NY2.51MShares$4.76 Million0.07% of portfolio
-
Propel Bio Management, LLC Los Angeles, CA1.79MShares$3.4 Million4.22% of portfolio
-
Alta Fundamental Advisers LLC New York, NY1.4MShares$2.66 Million1.22% of portfolio
About Milestone Pharmaceuticals Inc.
- Ticker MIST
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 30,010,900
- Market Cap $57M
- Description
- Milestone Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of cardiovascular medicines. The company is developing etripamil, a novel channel blocker, which is in Phase III clinical trial for the treatment of paroxysmal supraventricular tachycardia in the United States and Canada; and Phase II cl...